Consilium Wealth Advisory’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Consilium Wealth Advisory's ABBV Position: Q3 2026 in Review
Consilium Wealth Advisory increased its AbbVie (ABBV) stake by 6.7% in Q3 2026, buying an estimated $105K and bringing the position to 6,560 shares worth $1.72M. The position accounts for 0.51% of the portfolio, ranked #39.
Consilium Wealth Advisory first reported a position in ABBV in Q4 2021 and has held it in 20 quarters since. 2,418 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Consilium Wealth Advisory held 6,560 shares of AbbVie worth $1.72M as of Q3 2026.
- Consilium Wealth Advisory bought 411 AbbVie shares in Q3 2026, an estimated $105K.
- AbbVie made up 0.51% of Consilium Wealth Advisory's portfolio in Q3 2026, its #39 holding.
- Consilium Wealth Advisory first reported a position in AbbVie in Q4 2021 and has held it in 20 quarters since.
- 2,418 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Consilium Wealth Advisory's 13F filing for Q3 2026, filed 14 Oct 2026.